A new TB vaccine: fact or fiction?. van Helden, P. D. & Hoal, E. G. Comparative Immunology, Microbiology and Infectious Diseases, 36(3):287–294, May, 2013. 00004
doi  abstract   bibtex   
Vaccination has been spectacularly successful in eradicating or controlling some infectious diseases, and is particularly attractive as an approach to tackling other infectious diseases. Although vaccination against tuberculosis has been done for nearly 100 years, it is clearly not that successful since the disease still occurs at epidemic levels in animals and humans in many areas. New approaches to vaccination against TB in humans and animals are currently in the pipeline, but none show either complete protection or sterilization. However, there is evidence to suggest that vaccination may deliver some positive outcomes. Not only should we be investigating new vaccines, but also how vaccines and candidates are used and delivered. There are many reasons to think that this task will not be simple, or perhaps not possible in some cases. We present different aspects of the development of vaccines against TB, outline some complications and suggest some new ways to consider this problem.
@article{van_helden_new_2013,
	title = {A new {TB} vaccine: fact or fiction?},
	volume = {36},
	issn = {1878-1667},
	shorttitle = {A new {TB} vaccine},
	doi = {10.1016/j.cimid.2012.07.003},
	abstract = {Vaccination has been spectacularly successful in eradicating or controlling some infectious diseases, and is particularly attractive as an approach to tackling other infectious diseases. Although vaccination against tuberculosis has been done for nearly 100 years, it is clearly not that successful since the disease still occurs at epidemic levels in animals and humans in many areas. New approaches to vaccination against TB in humans and animals are currently in the pipeline, but none show either complete protection or sterilization. However, there is evidence to suggest that vaccination may deliver some positive outcomes. Not only should we be investigating new vaccines, but also how vaccines and candidates are used and delivered. There are many reasons to think that this task will not be simple, or perhaps not possible in some cases. We present different aspects of the development of vaccines against TB, outline some complications and suggest some new ways to consider this problem.},
	language = {eng},
	number = {3},
	journal = {Comparative Immunology, Microbiology and Infectious Diseases},
	author = {van Helden, Paul D. and Hoal, Eileen G.},
	month = may,
	year = {2013},
	pmid = {22921282},
	note = {00004 },
	keywords = {Animals, BCG Vaccine, Disease Models, Animal, Humans, Mass Vaccination, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis Vaccines},
	pages = {287--294},
}

Downloads: 0